טוען...
Clinical and Immunological Outcome in Cutaneous Leishmaniasis Patients Treated with Pentoxifylline
Pentoxifylline is a tumor necrosis factor-α (TNF-α) inhibitor that also attenuates the immune response and decreases tissue inflammation. The association of pentoxifylline with antimony improves the cure rate of mucosal and cutaneous leishmaniasis. In this randomized and double blind pilot trial, cu...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
The American Society of Tropical Medicine and Hygiene
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973503/ https://ncbi.nlm.nih.gov/pubmed/24567316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.12-0729 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|